PureTech Health (PRTC) News Today $17.35 -0.66 (-3.66%) Closing price 03:59 PM EasternExtended Trading$17.35 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period PureTech Health plc (PRTC) Q2 2025 Earnings Conference Call TranscriptAugust 28 at 5:01 PM | seekingalpha.comPureTech Health plc – Half-Year ReportAugust 28 at 2:00 AM | businesswire.comPureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Down 39.6% in JulyAugust 21, 2025 | marketbeat.comPureTech Health: Notice of Half-Yearly ResultsAugust 18, 2025 | businesswire.comPureTech Health (NASDAQ:PRTC) Trading Up 1.4% - Still a Buy?August 15, 2025 | marketbeat.comPureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary EndpointAugust 13, 2025 | businesswire.comPureTech Health plc: PureTech Announces Board ChangeJuly 31, 2025 | finanznachrichten.dePureTech Health (NASDAQ:PRTC) Shares Down 7.3% - Here's What HappenedJuly 23, 2025 | marketbeat.comPureTech Health CEO Bharatt Chowrira ResignsJuly 16, 2025 | marketwatch.comPureTech Announces Leadership TransitionJuly 16, 2025 | businesswire.comPureTech Health announces board chair Raju Kucherlapati steps downJuly 10, 2025 | investing.comPureTech Health plc (PRTC) Income Statement - Yahoo FinanceJuly 9, 2025 | finance.yahoo.comPureTech Announces Board ChangeJuly 8, 2025 | businesswire.comPureTech Health (NASDAQ:PRTC) Trading 0.6% Higher - Still a Buy?July 1, 2025 | marketbeat.comWhy This Biotech Stock Just Doubled In A Single DayJune 26, 2025 | benzinga.comMillennium Management LLC Invests $823,000 in PureTech Health plc (NASDAQ:PRTC)June 7, 2025 | marketbeat.comPureTech Health plc (NASDAQ:PRTC) Sees Large Decline in Short InterestJune 3, 2025 | marketbeat.comPureTech Health (NASDAQ:PRTC) Stock Price Down 4.2% - Time to Sell?May 28, 2025 | marketbeat.comPureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF TrialMay 22, 2025 | businesswire.comPureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF)May 9, 2025 | businesswire.comLeerink Partnrs Predicts PureTech Health FY2025 EarningsMay 6, 2025 | marketbeat.comPureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International ConferenceMay 1, 2025 | finance.yahoo.comPureTech Health plc (PRTC) Q4 2024 Earnings Call TranscriptApril 30, 2025 | seekingalpha.comPureTech Announces Annual Results for Year Ended December 31, 2024April 30, 2025 | businesswire.comPureTech Health Stock Price, Quotes and Forecasts | NASDAQ:PRTC | BenzingaApril 22, 2025 | benzinga.comPureTech Health plc (NASDAQ:PRTC) Short Interest Down 61.5% in MarchApril 17, 2025 | marketbeat.comLeerink Partners Keeps Their Buy Rating on PureTech Health (PRTC)April 10, 2025 | markets.businessinsider.comPureTech Appoints Peel Hunt as Joint UK Corporate BrokerApril 9, 2025 | businesswire.comPureTech Appoints Peel Hunt as Joint UK Corporate BrokerApril 9, 2025 | businesswire.comPureTech Health Shares Fall After Nordic Capital Withdraws Offer PlanApril 8, 2025 | marketwatch.comPureTech Health plc Statement Regarding Press SpeculationApril 7, 2025 | businesswire.comPureTech Health (NASDAQ:PRTC) Trading 3.5% Higher - Still a Buy?March 25, 2025 | marketbeat.comPureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee ChairMarch 11, 2025 | finance.yahoo.comPureTech Health (NASDAQ:PRTC) Stock Price Up 2.5% - What's Next?March 4, 2025 | marketbeat.comPureTech to Present at the Leerink Partners Global Healthcare ConferenceFebruary 25, 2025 | finance.yahoo.comPureTech Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via ...February 12, 2025 | businesswire.comBirch Hill Investment Advisors LLC Takes $5.58 Million Position in PureTech Health plc (NASDAQ:PRTC)February 9, 2025 | marketbeat.comPureTech Health plc (NASDAQ:PRTC) Short Interest UpdateJanuary 31, 2025 | marketbeat.comPureTech Health Plc (NASDAQ: PRTC)January 30, 2025 | fool.comPureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature MedicineJanuary 27, 2025 | finance.yahoo.comPureTech Health plc (NASDAQ:PRTC) Short Interest Up 77.7% in DecemberJanuary 15, 2025 | marketbeat.comPureTech Drug Gets FDA Fast-Track Designation for LeukemiaJanuary 9, 2025 | marketwatch.comPureTech Says FDA Grants Fast Track Designation For LYT-200 In Acute Myeloid LeukemiaJanuary 9, 2025 | markets.businessinsider.comPureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)January 9, 2025 | businesswire.comPureTech Appoints UBS as UK Corporate BrokerJanuary 6, 2025 | businesswire.comPureTech Health (NASDAQ:PRTC) Sees Unusually-High Trading Volume - Time to Buy?December 19, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down - Here's WhyDecember 17, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Up - Should You Buy?December 16, 2024 | marketbeat.comPureTech's Deupirfenidone Shows Positive Results In Slowing Lung Function Decline In IPF PatientsDecember 16, 2024 | markets.businessinsider.comPureTech's Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b TrialDecember 16, 2024 | businesswire.com Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRTC Media Mentions By Week PRTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTC News Sentiment▼1.141.03▲Average Medical News Sentiment PRTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTC Articles This Week▼41▲PRTC Articles Average Week Get the Latest News and Ratings for PRTC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for PureTech Health and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DYN News APGE News TWST News BEAM News CDTX News IMCR News BHVN News WVE News AUPH News TVTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access